Simply Good Foods' Turnaround: A Price Hike and a P&L Rebuild in the Shadow of a 75% Drawdown

The packaged-foods maker is three quarters into a reset — fresh pricing, a Quest agency change, and a marketing mix shift — but the economics of the turnaround hinge on a high single-digit September price increase while the stock sits near a historic low.

SMPL · Earnings Call · 2026-07-09

A Company in the Early Stages of a Fix-It Story

When Joe Scalzo retook the helm at consumer demand company Simply Good Foods (SMPL), he inherited a P&L under assault from protein and packaging inflation, a shrinking Atkins franchise, and an distribution losses problem at OWYN. The third-quarter fiscal 2026 print (period ended May 30) beat expectations — “Our results came in ahead of our expectations. While we're not satisfied with our overall performance, the quarter reinforced our belief that the actions we are taking are the right ones.” — Joe Scalzo, President and CEO · 2026-07-09 Yet the dashboard is stark: net sales fell 6.3% to $357 million, gross margin dropped 390 basis points to 32.5%, and adjusted EBITDA declined 22.5% to $57.2 million. The market’s reaction has been muted — the stock sits at a 75.6% drawdown from its April 2022 peak, though the recent 90-day trend is slightly positive (+4.2%), a small pause in a long decline. The fundamental numbers confirm the erosion. Gross margin has fallen from a high of 48.1% in 2018 to 31.6% in the latest quarter. The company’s operating income swung to a -$218M loss on an impairment charge and softer core operations. The price-to-revenue multiple has collapsed from 4.9x to 0.9x, a clear signal that investors have yet to trust the turnaround narrative. In that context, the company’s decision to push through a high single-digit price increase in September is a pivotal test of consumer tolerance and a direct answer to the margin problem.

The New Pricing Action and the Cost Conundrum

The most concrete new development on the call was the announcement of a “high single-digit price increase across most of our portfolio that will become effective in September.” — Joe Scalzo, President and CEO · 2026-07-09 CFO Chris Bealer explained the rationale: “We are seeing input inflation across multiple areas of the business... we feel that's appropriate to offset input inflation.” — Chris Bealer, Chief Financial Officer · 2026-07-09 This is a departure from the prior management’s more cautious pricing stance. In the January 2026 call, Geoff Tanner (prior CEO) spoke about pricing only in the context of "mid- to high-single-digit" increases but expected elasticities to burn off. Now, with a new CEO, the tone is sharper: elasticities are explicitly expected to be "at one or higher," and pricing action is a core weapon to rebuild gross margin toward the long-term algorithm of ~40%. The company is also leaning on productivity initiatives to offset some of the same inflation, but the price hike is the bigger lever. In the prior quarter’s Q&A, the team was more defensive, saying they had "good line of sight" on costs and expecting a natural lag to resolve. Now the urgency is palpable: the September increase will hit just as the company enters a period of expected distribution losses on OWYN and reset on Atkins. The market is watching whether the consumer will accept the higher price — and the tape is already punishing the stock for the risk. The consumer insight work that management cites to justify the pricing is a deliberate pivot: they are reasserting the brand’s nutritional superiority to justify the price, rather than relying on promotional support. That is a confident move, but it carries execution risk.

Quest as the Engine, and the Bar Problem

The core of the turnaround is Quest. “Quest remains our largest brand and most important growth engine... household penetration increased 120 basis points year-over-year to 20.5%.” — Joe Scalzo, President and CEO · 2026-07-09 Quest chips are growing 17% in consumption, and the milkshake line is up 50% from a small base. But the bar business, the biggest chunk, declined ~5% in the quarter. Management attributes that to a marketing investment imbalance — too much spend on lower-funnel activation and not enough on top-of-funnel to sustain the bar buy rate. They hired a new agency to fix the message: “we hired a new marketing agency on Quest with a single-minded objective of improving brand message to our key target consumer group by reasserting our superior nutritionals and taste.” — Joe Scalzo, President and CEO · 2026-07-09 This is a direct admission that the brand’s core proposition was diluted, and it aligns with a rotation impact — a club bar rotation that will continue into Q4 but burn off in 2027. The contrast with the prior management’s tone is stark. On the January call, Geoff Tanner said “we are obviously not happy with flat... that doesn't work. It's unacceptable.” — Geoff Tanner, President and Chief Executive Officer · 2026-01-08 Now management is more surgical: they know the bar decline is a function of innovation misses and top-of-funnel neglect. They have a plan to fix it, but the third-quarter result shows the plan hasn’t taken hold yet. The stock’s recent 90-day trend (+4.2%) suggests some optimism, but the full history remains deeply negative. Investors will be watching whether the new agency and the price increase can stop the bar bleed in the next two quarters.

GLP-1 as the New Frontier

A standout theme on the call was the explicit discussion of GLP-1 therapies. Management has completed a consumer study and is actively leaning into the opportunity. “Atkins can play a meaningful role in a GLP-1 world... we just completed a thorough assessment of GLP-1 therapies and their impact on consumption behaviors.” — Joe Scalzo, President and CEO · 2026-07-09 This is a step forward from the prior management’s posture, which spoke about GLP-1 in the context of being a "companion" to the drug. Now they are talking about high interactivity between Atkins buyers and GLP-1 users, and they plan to test new marketplace ideas next year. This is a funnel marketing shift — they see a chance to recruit consumers who are managing weight with drugs and then maintain with Atkins products. The global keyword set confirms GLP-1 is a broad theme (see GLP 1 in the company trajectory and affordability benefit in the global list), but for SMPL it’s a hinge: the company is betting that Atkins can stabilize as a weight-management companion. The problem: Atkins consumption is still falling 23.9% in the quarter. The GLP-1 pivot is a long-term bet that needs the household penetration decline to flatten first. The valuation (price-to-FCF at 9.8x) suggests the market is not giving credit for that optionality yet. Overall, this is a classic turnaround story in its early innings — the company has identified the problems, taken decisive pricing action, and is rebuilding the marketing machine, but the evidence of success is still thin. The

I'd like to answer that question for you maybe the next time we get together when we're closer to the marketplace
Joe Scalzo, President and CEO · 2026-07-09

— that was Scalzo deferring on GLP-1 specifics, which sums up the state: promise, but not yet proof. The September price increase and the Quest agency work are the two catalysts to watch over the next two quarters. If the consumer accepts the price and the bar business recovers, the stock has significant upside from a distressed level. If not, the drawdown deepens. The interestingness here is high because this is a company with a broken P&L, a new CEO, and a bold pricing move — all against a backdrop of a 75% drawdown. It’s a name-in-motion with a clear thesis and a right-now trigger.